Article

Minimally Invasive Versus Sternotomy Approach for Mitral Valve Surgery in Patients Greater Than 70 Years Old: A Propensity-Matched Comparison

Department of Cardiac Surgery, Heart Center Leipzig, Leipzig, Germany.
The Annals of thoracic surgery (Impact Factor: 3.65). 02/2011; 91(2):401-5. DOI: 10.1016/j.athoracsur.2010.08.006
Source: PubMed

ABSTRACT The goal of this study was to compare the outcome after mitral valve surgery through either standard sternotomy or right lateral minithoracotomy in elderly patients with higher perioperative risk.
All 1,027 elderly patients (>70 years) who received isolated mitral valve surgery (± tricuspid valve repair) between August 1999 and July 2009 were analyzed for outcome differences due to surgical approach using propensity score matching. The etiology of mitral valve disease was degenerative (83%), endocarditis (6%), rheumatic (10%), and acute ischemic (<1%). Isolated stenosis was rare (3%); most patients had mitral valve regurgitation (72%) or combined mitral valve disease (25%).
The minimally invasive approach led to longer duration of surgery (186 ± 61 vs 169 ± 59 minutes, p = 0.01), cardiopulmonary bypass time (142 ± 54 vs 102 ± 45 minutes, p = 0.0001), and cross-clamp time (74 ± 44 vs 64 ± 28 minutes, p = 0.015). There were no differences between the matched groups in 30-day mortality (7.7% vs 6.3%, p = 0.82), combined major adverse cardiac and cerebrovascular events (11.2% vs 12.6%, p = 0.86), or other postoperative outcome. Only the number of postoperative arrhythmias and pacemaker implants was higher in the sternotomy group (65.7% vs 50.3%, p = 0.023 and 18.9% vs 10.5%, p = 0.059). Long-term survival was 66% ± 5.6% vs 56 ± 5.5% at 5 years and 35% ± 12% vs 40% ± 7.9% at 8 years, and did not show significant differences.
Minimally invasive mitral valve surgery through a right lateral minithoracotomy is at least as good and safe as the standard sternotomy approach in elderly patients.

0 Followers
 · 
80 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The study objective was to review a single-center experience on robotic mitral valve repair to treat mitral regurgitation, with a specific focus on midterm echocardiographic mitral durability. No data assessing the quality or durability of repaired mitral valves are currently available.
    Journal of Thoracic and Cardiovascular Surgery 08/2014; DOI:10.1016/j.jtcvs.2014.07.054 · 3.99 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Minimally invasive mitral valve surgery (MIMVS) through a right lateral thoracotomy has emerged as another option in cardiac surgery. We present our single center experience with regards to repair rate and durability of the repair in patients undergoing MIMVS. Methods: Between January 2009 and December 2012 a total of 312 consecutive patients underwent MIMVS. Baseline characteristics, operative variables, postoperative outcomes, and follow-up information about survival, major adverse cardiac and cerebrovascular event (MACCE)-free survival, valve competence, and freedom from reoperation were collected. Results: Mean age was 61 +/- 13.1 years, median Euroscore 4 (0-13). The predominant valve pathology was degenerative disease (96.2%) with regurgitation (95.2%) and atrial fibrillation (23.1%). Bypass time was 147 +/- 46, cross-clamp time 94 +/- 32 minutes. All degenerative valves planned for repair (n = 281) were successfully repaired except for two (0.7%) resulting in a 99.3% repair rate. Eight patients (2.8%) had to be converted to sternotomy. Median ventilation time was 6.6 hours (0 to 460), ICU stay one day (0 to 96), and hospital stay eight days (3 to 61). Most of the patients did not need red blood cell transfusion (78.2%). One patient died in hospital due to acute respiratory distress syndrome (0.3%) and five suffered a permanent stroke (1.6%). In 294 patients (94.5%) follow-up was completed for a median of 22 months (0 to 53) with 95.5 +/- 1.2% overall survival, 96.8 +/- 1.2%, MACCE-free survival, and 94.8 +/- 0.1% freedom from reoperation. Conclusions: MIMVS is a safe approach with low morbidity and mortality that allows a high and durable repair rate with low reoperation rates and favorable short-term event-free survival.
    Journal of Cardiac Surgery 08/2014; 29(6). DOI:10.1111/jocs.12439 · 0.89 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Minimal invasive mitral valve surgery (MIMVS) has emerged as an alternative approach to conventional sternotomy to perform mitral valve repair and replacement with equivalent results. This strategy was developed to decrease surgical trauma by minimizing the size of incisions and permits excellent exposure of the mitral valve thereby avoiding conventional full sternotomy. The purpose of this review is to provide a critical, objective, balanced, and evidence-based analysis of the literature to understand advantages, potential scope, and the utility of these minimal invasive approaches to the mitral valve in modern cardiac care. Copyright © 2015 Elsevier Inc. All rights reserved.